chartexchange

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Southern California for the Expanded Mindfulness Assisted Psychedelic Therapy Trial

Newsfile | Nov 3, 2026 8:02 AM EST

Filament has shipped PEX010 to the Keck School of Medicine of USC for the first order under the expanded supply agreement for its Mindfulness Assisted Psychedelic Therapy trial.Toronto, Ontario--(Newsfile Corp. - November 3, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"),...

Read original article